Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05482126 · ClinicalTrials.gov registry record
Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease
A clinical trial of Parkinson Disease, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05482126 is a study of Parkinson Disease that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05482126, a study of Parkinson Disease, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are investigating the brain activity associated with sensory information in movement disorders in order to improve treatment of these symptoms beyond what is currently available.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Intraoperative Behavioral Testing
- DIAGNOSTIC_TEST Behavioral Testing
Study Locations (1)
Alabama
- The University of Alabama at Birmingham Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-06-08 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05482126
The ClinicalTrials.gov registry entry for NCT05482126 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Intraoperative Behavioral Testing is the first listed.
NCT05482126 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT05482126 about?
NCT05482126 is a clinical study titled "Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease". The investigators are investigating the brain activity associated with sensory information in movement disorders in order to improve treatment of these symptoms beyond what is currently available.
What is the current status of trial NCT05482126?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2022-06-08. Estimated completion is 2026-12-31.
What conditions does trial NCT05482126 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT05482126?
The interventions under investigation include: Intraoperative Behavioral Testing (DIAGNOSTIC_TEST), Behavioral Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05482126?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05482126 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.